VanEck Pharmaceutical ETF (PPH)

♥ 303 Thanks from members

The VanEck Pharmaceutical ETF (PPH) presents a medium-risk profile with concentrated global pharmaceutical exposure, delivering strong trailing returns though tempered by high single-stock weightings like Eli Lilly and ongoing drug pricing policy risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Pharmaceuticals ETF Founder: VanEck Leadership: Jan van Eck (CEO, VanEck) Holder: Morgan Stanley Holder: Wells Fargo & Company Holder: Bank of America VanEck Pharmaceutical ETF #PPH ETF #VanEck Pharmaceutical #Pharma ETF #NASDAQ PPH #Healthcare stocks